Will We Have a Match? Observations from Decision Making Conversations Between Hematologists and White and Black Patients Considering Allogeneic Stem Cell Transplant
Journal of Clinical Oncology (2023) Authors: Thorunn Halldora Thordardottir, Rachel A. Rodenbach, Toby Christopher Campbell Abstract: Allogeneic stem cell transplant (alloSCT) is the only treatment associated with cure for high-risk myelodysplastic syndrome (MDS), but carries substantial risks. One routinely mentioned concern is donor source. While white patients have an 80% chance of finding an unrelated fully matched …